Robert Loberg serves as a HealthTech Advisory Board Member at Cota Capital since September 2022 and holds the position of Vice President, Lifecycle Leader - Oncology & Genetics at Roche since June 2020. At Roche, responsibilities encompass the development and commercialization of next-generation sequencing assays and oncology PCR products, alongside managing a global lifecycle team. Prior to this, Robert spent nearly 13 years at Amgen, culminating in the role of Executive Director, overseeing the biomarker and diagnostic strategy for multiple therapeutic areas. Robert's extensive experience includes leadership roles in clinical biomarkers and diagnostics, managing large teams across various sites, and fostering partnerships in diagnostic development. Academic credentials include a PhD in Physiology from the University of Michigan and degrees from Baylor University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices